Jinjun Shi

Active 2001–2025

92
Papers
23,602
Citations
64
h-index
85
i10-index

Citations

Citations per year for Jinjun Shi1990: 1 citations2003: 4 citations2004: 2 citations2005: 5 citations2006: 5 citations2007: 5 citations2008: 7 citations2009: 9 citations2010: 8 citations2011: 43 citations2012: 62 citations2013: 60 citations2014: 83 citations2015: 108 citations2016: 157 citations2017: 273 citations2018: 395 citations2019: 1,028 citations2020: 1,244 citations2021: 1,264 citations2022: 1,166 citations2023: 1,121 citations2024: 1,535 citations2025: 902 citations2026: 21 citations1991–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,288 citing papers, 36.7% of this breakdownUnited States: 2,031 citing papers, 17.4% of this breakdownIndia: 503 citing papers, 4.3% of this breakdownSouth Korea: 352 citing papers, 3% of this breakdownUnited Kingdom: 290 citing papers, 2.5% of this breakdownGermany: 283 citing papers, 2.4% of this breakdownItaly: 257 citing papers, 2.2% of this breakdownAustralia: 255 citing papers, 2.2% of this breakdownIran: 242 citing papers, 2.1% of this breakdownCanada: 212 citing papers, 1.8% of this breakdownSpain: 187 citing papers, 1.6% of this breakdownSingapore: 184 citing papers, 1.6% of this breakdown
0%36.7%Other 22.2%

Fields

  • Biochemistry, Genetics and Molecular Biology30.6%
  • Materials Science19.4%
  • Engineering18.9%
  • Medicine15.3%
  • Immunology and Microbiology9.2%
  • Pharmacology, Toxicology and Pharmaceutics2.1%
  • Other4.5%

Topics

  • Nanoplatforms for cancer theranostics9.7%
  • RNA Interference and Gene Delivery9.3%
  • Nanoparticle-Based Drug Delivery8.9%
  • Advanced biosensing and bioanalysis techniques6.4%
  • Immunotherapy and Immune Responses2.8%
  • Extracellular vesicles in disease2.5%
  • Other60.4%

Coauthors

All papers

Open in search
  1. Cancer nanomedicine: progress, challenges and opportunities

    Authors: , , , - Nature reviews. Cancer 2016 cited by 5,628

  2. Nanodelivery of nucleic acids

    Authors: , , , , , , , , , , , , - Nature Reviews Methods Primers 2022 cited by 650

  3. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis

    Authors: , , , , , - Nature Reviews Cardiology 2021 cited by 501

  4. Hydrogels for RNA delivery

    Authors: , , , , , , - Nature Materials 2023 cited by 336

  5. Efferocytosis induces macrophage proliferation to help resolve tissue injury

    Authors: , , , , , , , , , , - Cell Metabolism 2021 cited by 347

  6. Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

    Authors: , , , , , , , , , , , , , - Nature Communications 2022 cited by 257

  7. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53 -deficient cancers to mTOR inhibition

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2019 cited by 306

  8. Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models

    Authors: , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 246

  9. siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice

    Authors: , , , , , , , , , , , - Science Translational Medicine 2020 cited by 240

  10. Comprehensive Insights into the Multi-Antioxidative Mechanisms of Melanin Nanoparticles and Their Application To Protect Brain from Injury in Ischemic Stroke

    Authors: , , , , , , - Journal of the American Chemical Society 2016 cited by 544

  11. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA

    Authors: , , , , , , , , , , , , , , , , , , - Nature Biomedical Engineering 2018 cited by 338

  12. Insight into nanoparticle cellular uptake and intracellular targeting

    Authors: , , , , , - Journal of Controlled Release 2014 cited by 770

  13. ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy

    Authors: , , , , , , , , , , , - Advanced Materials 2017 cited by 499

  14. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice

    Authors: , , , , , , , , , , , - Biomaterials 2020 cited by 221

  15. ROS-Responsive Nanoparticle Delivery of mRNA and Photosensitizer for Combinatorial Cancer Therapy

    Authors: , , , , , , , , - Nano Letters 2023 cited by 74

  16. Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics

    Authors: , , , , , , , , , , - Advanced Materials 2016 cited by 881

  17. Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo

    Authors: , , , , , , , , , , - Theranostics 2017 cited by 130

  18. ‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective

    Authors: , , , , , - Chemical Society Reviews 2023 cited by 83

  19. Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications

    Authors: , , , - Nano Letters 2010 cited by 1,589

  20. Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity

    Authors: , , , , , , , , , , , , , , , - Cardiovascular Research 2021 cited by 99

  21. Structural Transformative Antioxidants for Dual‐Responsive Anti‐Inflammatory Delivery and Photoacoustic Inflammation Imaging

    Authors: , , , , , , , , , , - Angewandte Chemie International Edition 2021 cited by 109

  22. Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles

    Authors: , , , , , , , , , , , - Nature Biomedical Engineering 2022 cited by 50

  23. Nanotechnology for protein delivery: Overview and perspectives

    Authors: , , , - Journal of Controlled Release 2015 cited by 395

  24. RNA Nanotechnology-Mediated Cancer Immunotherapy

    Authors: , , , , , , - Theranostics 2019 cited by 157